Diantha Duvall
Director of Finance/CFO bij CURIS, INC.
Vermogen: - $ op 31-03-2024
Profiel
Diantha Duvall is currently the Director at BioTheryX, Inc. since 2021 and the CFO, Treasurer & Chief Accounting Officer at Curis, Inc. since 2022.
Previously, she worked as the Executive Director at Merck & Co., Inc. from 2009 to 2015, the Global Commercial Controller at Biogen, Inc. from 2016 to 2017, the Chief Financial Officer at Genocea Biosciences, Inc. from 2019 to 2022, and the Chief Accounting Officer, VP & Controller at Bioverativ, Inc. from 2017 to 2019.
Ms. Duvall completed her undergraduate degree at Colby College and holds a graduate degree and an MBA from Northeastern University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
CURIS, INC.
-.--% | 31-07-2023 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van Diantha Duvall
| Bedrijven | Functie | Begin |
|---|---|---|
| CURIS, INC. | Director of Finance/CFO | 05-08-2022 |
BioTheryX, Inc.
 BioTheryX, Inc. Pharmaceuticals: MajorHealth Technology BioTheryX, Inc. pengages in the development of clinical drugs. It focuses on the restoration of protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition. The company was founded by David I. Stirling and Lawrence Zaslow in 2007 and is headquartered in Chappaqua, NY. | Director/Board Member | 09-08-2021 |
Eerdere bekende functies van Diantha Duvall
| Bedrijven | Functie | Einde |
|---|---|---|
| GENOCEA BIOSCIENCES, INC. | Director of Finance/CFO | 01-07-2022 |
| BIOVERATIV INC | Comptroller/Controller/Auditor | 01-01-2019 |
| BIOGEN INC. | Corporate Officer/Principal | 01-01-2017 |
| MERCK & CO., INC. | Director/Board Member | 01-01-2015 |
Opleiding van Diantha Duvall
| Colby College | Undergraduate Degree |
| Northeastern University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| BIOGEN INC. | Health Technology |
| CURIS, INC. | Health Technology |
| GENOCEA BIOSCIENCES, INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
BioTheryX, Inc.
BioTheryX, Inc. Pharmaceuticals: MajorHealth Technology BioTheryX, Inc. pengages in the development of clinical drugs. It focuses on the restoration of protein homeostasis, including protein degradation and modulation, and multi-kinase inhibition. The company was founded by David I. Stirling and Lawrence Zaslow in 2007 and is headquartered in Chappaqua, NY. | Health Technology |
Bioverativ, Inc.
 Bioverativ, Inc. BiotechnologyHealth Technology Bioverativ, Inc. is a global biopharmaceutical company, focused on discovery, research, development and commercialization of therapies for the treatment of blood diseases including hemophilia. The company is headquartered in Cambridge, MA. | Health Technology |
